{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T16:49:06Z","timestamp":1772815746899,"version":"3.50.1"},"reference-count":74,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.cbi.2006.12.009","type":"journal-article","created":{"date-parts":[[2006,12,29]],"date-time":"2006-12-29T07:11:08Z","timestamp":1167376268000},"page":"51-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Induction of drug metabolizing enzymes: A survey of in vitro methodologies and interpretations used in the pharmaceutical industry\u2014Do they comply with FDA recommendations?"],"prefix":"10.1016","volume":"168","author":[{"given":"Nicola J.","family":"Hewitt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruben","family":"de Kanter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"LeCluyse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2006.12.009_bib1","article-title":"Guidance for industry: drug interaction studies\u2014study design, data analysis, and implications for dosing and labelling","author":"Huang","year":"2006","journal-title":"Draft Guidance"},{"issue":"8","key":"10.1016\/j.cbi.2006.12.009_bib2","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1023\/A:1010994022294","article-title":"Optimizing drug development: strategies to assess drug metabolism\/transporter interaction potential\u2014toward a consensus","volume":"18","author":"Tucker","year":"2001","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.cbi.2006.12.009_bib3","first-page":"443","article-title":"Pharmaceutical research and manufacturers of america drug metabolism\/clinical pharmacology technical working groups. The conduct of in vitro and in vivo drug\u2013drug interaction studies: a PhRMA perspective","volume":"43","author":"Bjornsson","year":"2003","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.cbi.2006.12.009_bib4","unstructured":"S.-M. Huang, Drug interaction studies\u2014study design, data analysis, and implications for dosing and labelling. Preliminary concept paper. October 2004, http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/04\/briefing\/2004-4079b1.htm."},{"issue":"3","key":"10.1016\/j.cbi.2006.12.009_bib5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0009-2797(01)00162-4","article-title":"Species comparison in P450 induction: effects of dexamethasone, omeprazole, and rifampin on P450 isoforms 1A and 3A in primary cultured hepatocytes from man, Sprague\u2013Dawley rat, minipig, and beagle dog","volume":"134","author":"Lu","year":"2001","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2006.12.009_bib6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0169-409X(96)00417-6","article-title":"The use of adult human hepatocytes in primary culture and other in vitro systems to investigate drug metabolism in man","volume":"22","author":"Maurel","year":"1996","journal-title":"Adv. Drug Del. Rev."},{"issue":"1","key":"10.1016\/j.cbi.2006.12.009_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2165\/00003088-199631010-00002","article-title":"Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole","volume":"31","author":"Andersson","year":"1996","journal-title":"Clin. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.cbi.2006.12.009_bib8","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0022-3565(25)38702-1","article-title":"Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture","volume":"269","author":"Curi-Pedrosa","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.cbi.2006.12.009_bib9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1582-4934.2002.tb00186.x","article-title":"Cytochromes P450 and experimental models of drug metabolism","volume":"6","author":"Zuber","year":"2002","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.cbi.2006.12.009_bib10","first-page":"381","article-title":"Activation of carcinogens by human liver cytochromes P-450","volume":"53","author":"Guengerich","year":"1990","journal-title":"Basic Life Sci."},{"issue":"10","key":"10.1016\/j.cbi.2006.12.009_bib11","first-page":"1325","article-title":"Calcium channel modulators of the dihydropyridine family are human pregnane X receptor activators and inducers of CYP3A, CYP2B, and CYP2C in human hepatocytes","volume":"29","author":"Drocourt","year":"2001","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.cbi.2006.12.009_bib12","first-page":"242","article-title":"Induction of CYP2C genes in human hepatocytes in primary culture","volume":"29","author":"Gerbal-Chaloin","year":"2001","journal-title":"Drug Metab. Dispos."},{"issue":"23","key":"10.1016\/j.cbi.2006.12.009_bib13","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1101\/gad.846800","article-title":"Reciprocal activation of xenobiotic response genes by nuclear receptors SXR\/PXR and CAR","volume":"14","author":"Xie","year":"2000","journal-title":"Genes Dev."},{"issue":"16","key":"10.1016\/j.cbi.2006.12.009_bib14","doi-asserted-by":"crossref","first-page":"12822","DOI":"10.1074\/jbc.M005930200","article-title":"Orphan receptor promiscuity in the induction of cytochromes p450 by xenobiotics","volume":"276","author":"Smirlis","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.cbi.2006.12.009_bib15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00003088-199835050-00003","article-title":"Inhibition and induction of cytochrome P450 and the clinical implications","volume":"35","author":"Lin","year":"1998","journal-title":"Clin. Pharmacokinet."},{"issue":"5","key":"10.1016\/j.cbi.2006.12.009_bib16","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1124\/dmd.31.5.620","article-title":"Glucocorticoid receptor enhancement of pregnane X receptor-mediated CYP2B6 regulation in primary human hepatocytes","volume":"31","author":"Wang","year":"2003","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.cbi.2006.12.009_bib17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/toxsci\/65.2.166","article-title":"Mechanisms of hepatotoxicity","volume":"65","author":"Jaeschke","year":"2002","journal-title":"Toxicol Sci."},{"issue":"6","key":"10.1016\/j.cbi.2006.12.009_bib18","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s11095-006-0277-7","article-title":"CYP induction-mediated drug interactions: in vitro assessment and clinical implications","volume":"23","author":"Lin","year":"2006","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.cbi.2006.12.009_bib19","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1124\/dmd.32.1.140","article-title":"An assessment of udp-glucuronosyltransferase induction using primary human hepatocytes","volume":"32","author":"Soars","year":"2004","journal-title":"Drug Metab. Dispos."},{"issue":"11","key":"10.1016\/j.cbi.2006.12.009_bib20","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/sj.onc.1209375","article-title":"Uridine diphosphoglucuronosyltransferase pharmacogenetics and cancer","volume":"25","author":"Nagar","year":"2006","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.cbi.2006.12.009_bib21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11095-004-9011-5","article-title":"Comparative effects of fibrates on drug metabolizing enzymes in human hepatocytes","volume":"22","author":"Prueksaritanont","year":"2005","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.cbi.2006.12.009_bib22","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.bcp.2003.11.002","article-title":"The induction of human UDP-glucuronosyltransferase 1A1 mediated through a distal enhancer module by flavonoids and xenobiotics","volume":"67","author":"Sugatani","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2006.12.009_bib23","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0076-6879(05)00006-6","article-title":"Regulation of the human UGT1A1 gene by nuclear receptors constitutive active\/androstane receptor, pregnane X receptor, and glucocorticoid receptor","volume":"400","author":"Sugatani","year":"2005","journal-title":"Meth. Enzymol."},{"issue":"5","key":"10.1016\/j.cbi.2006.12.009_bib24","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1046\/j.1365-2125.1999.00081.x","article-title":"Effects of cytochrome P450 inducers on 17alpha-ethinyloestradiol (EE2) conjugation by primary human hepatocytes","volume":"48","author":"Li","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.cbi.2006.12.009_bib25","first-page":"217","article-title":"Cytochrome-P450 induction and conjugated metabolism in primary human hepatocytes after cryopreservation","volume":"10","author":"Ruegg","year":"1997","journal-title":"In Vitro Toxicol."},{"issue":"3","key":"10.1016\/j.cbi.2006.12.009_bib26","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.bcp.2003.09.022","article-title":"Determination of cytochrome P450 1A2 and cytochrome P450 3A4 induction in cryopreserved human hepatocytes","volume":"67","author":"Roymans","year":"2004","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.cbi.2006.12.009_bib27","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1124\/dmd.104.003046","article-title":"Expression and induction potential of cytochromes P450 in human cryopreserved hepatocytes","volume":"33","author":"Roymans","year":"2005","journal-title":"Drug Metab. Dispos."},{"issue":"9","key":"10.1016\/j.cbi.2006.12.009_bib28","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1124\/dmd.105.009118","article-title":"Use of cryopreserved human hepatocytes in sandwich culture to measure hepatobiliary transport","volume":"34","author":"Bi","year":"2006","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.cbi.2006.12.009_bib29","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1096\/fasebj.3.2.2914628","article-title":"Hepatocyte function and extracellular matrix geometry: long-term culture in a sandwich configuration","volume":"176","author":"Dunn","year":"1989","journal-title":"FASEB J."},{"issue":"2\/3","key":"10.1016\/j.cbi.2006.12.009_bib30","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.tox.2005.10.017","article-title":"Effects of cell culture conditions on primary rat hepatocytes-cell morphology and differential gene expression","volume":"218","author":"Tuschl","year":"2006","journal-title":"Toxicology"},{"issue":"13","key":"10.1016\/j.cbi.2006.12.009_bib31","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1096\/fasebj.10.13.8940293","article-title":"Effect of extracellular matrix topology on cell structure, function, and physiological responsiveness: hepatocytes cultured in a sandwich configuration","volume":"10","author":"Berthiaume","year":"1996","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.cbi.2006.12.009_bib32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/(SICI)1099-0461(2000)14:4<177::AID-JBT1>3.0.CO;2-4","article-title":"Expression and regulation of cytochrome P450 enzymes in primary cultures of human hepatocytes","volume":"14","author":"LeCluyse","year":"2000","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.cbi.2006.12.009_bib33","doi-asserted-by":"crossref","first-page":"35669","DOI":"10.1074\/jbc.M103792200","article-title":"Polymorphism in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans","volume":"276","author":"Tirona","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.cbi.2006.12.009_bib34","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1080\/00498250210144811","article-title":"Permissive and suppressive effects of dexamethasone on enzyme induction in hepatocyte co-cultures","volume":"32","author":"Ringel","year":"2002","journal-title":"Xenobiotica"},{"issue":"24","key":"10.1016\/j.cbi.2006.12.009_bib35","doi-asserted-by":"crossref","first-page":"6346","DOI":"10.1046\/j.0014-2956.2001.02540.x","article-title":"Dual effect of dexamethasone on CYP3A4 gene expression in human hepatocytes. Sequential role of glucocorticoid receptor and pregnane X receptor","volume":"268","author":"Pascussi","year":"2001","journal-title":"Eur. J. Biochem."},{"issue":"3","key":"10.1016\/j.cbi.2006.12.009_bib36","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0304-4165(02)00483-X","article-title":"The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors","volume":"1619","author":"Pascussi","year":"2003","journal-title":"Biochim. Biophys. Acta."},{"issue":"2","key":"10.1016\/j.cbi.2006.12.009_bib37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1006\/abbi.1998.0730","article-title":"Induction of cytochrome P4503A by taxol in primary cultures of human hepatocytes","volume":"355","author":"Kostrubsky","year":"1998","journal-title":"Arch. Biochem. Biophys."},{"issue":"11","key":"10.1016\/j.cbi.2006.12.009_bib38","first-page":"542","article-title":"Dose dependent induction of CYP1A2 activity by omeprazole (Antra)","volume":"30","author":"Rost","year":"1992","journal-title":"Int. J. Clin. Pharmacol. Ther. Toxicol."},{"issue":"4","key":"10.1016\/j.cbi.2006.12.009_bib39","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/clpt.1994.49","article-title":"Accelerated caffeine metabolism after omeprazole treatment is indicated by urinary metabolite ratios: coincidence with plasma clearance and breath test","volume":"55","author":"Rost","year":"1994","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.cbi.2006.12.009_bib40","series-title":"Casserett and Doull's Toxicology. The Basic Science of Poisons","first-page":"133","article-title":"A biotransformation of xenobiotics","author":"Parkinson","year":"2001"},{"issue":"3","key":"10.1016\/j.cbi.2006.12.009_bib41","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.cbi.2006.09.013","article-title":"Fipronil induces CYP isoforms and cytotoxicity in human hepatocytes","volume":"164","author":"Das","year":"2006","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.cbi.2006.12.009_bib42","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0009-2797(99)00089-7","article-title":"Comparative effects of rifabutin and rifampicin on cytochromes P450 and UDP-glucuronosyl-transferases expression in fresh and cryopreserved human hepatocytes","volume":"121","author":"Reinach","year":"1999","journal-title":"Chem. Biol. Interact."},{"issue":"5","key":"10.1016\/j.cbi.2006.12.009_bib43","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1124\/dmd.31.5.533","article-title":"Regulation of CYP3A4 expression in human hepatocytes by pharmaceuticals and natural products","volume":"31","author":"Raucy","year":"2003","journal-title":"Drug Metab. Dispos."},{"issue":"Suppl. A","key":"10.1016\/j.cbi.2006.12.009_bib44","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/jac\/16.suppl_A.181","article-title":"Drug interactions and hepatitis produced by some macrolide antibiotics","volume":"16","author":"Pessayre","year":"1985","journal-title":"J. Antimicrob. Chemother."},{"issue":"9","key":"10.1016\/j.cbi.2006.12.009_bib45","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1124\/dmd.31.9.1170","article-title":"Concurrent induction and mechanism-based inactivation of CYP3A4 by an L-valinamide derivative","volume":"31","author":"Luo","year":"2003","journal-title":"Drug Metab. Dispos."},{"issue":"11","key":"10.1016\/j.cbi.2006.12.009_bib46","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1177\/0091270004269142","article-title":"Induction of CYP3A4 by efavirenz in primary human hepatocytes: comparison with rifampin and phenobarbital","volume":"44","author":"Hariparsad","year":"2004","journal-title":"J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.cbi.2006.12.009_bib47","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1124\/dmd.32.5.512","article-title":"Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures","volume":"32","author":"Komoroski","year":"2004","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.cbi.2006.12.009_bib48","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/toxsci\/kfh126","article-title":"Regulation of CYP2E1 by ethanol and palmitic acid and CYP4A11 by clofibrate in primary cultures of human hepatocytes","volume":"79","author":"Raucy","year":"2004","journal-title":"Toxicol. Sci."},{"issue":"6","key":"10.1016\/j.cbi.2006.12.009_bib49","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0090-9556(24)15146-X","article-title":"In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil","volume":"28","author":"Robertson","year":"2000","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.cbi.2006.12.009_bib50","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1124\/dmd.32.3.348","article-title":"Regulation of CYP2B6 in primary human hepatocytes by prototypical inducers","volume":"32","author":"Faucette","year":"2004","journal-title":"Drug Metab. Dispos."},{"issue":"4","key":"10.1016\/j.cbi.2006.12.009_bib51","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2133\/dmpk.20.236","article-title":"The quantitative prediction of in vivo enzyme-induction caused by drug exposure from in vitro information on human hepatocytes","volume":"20","author":"Kato","year":"2005","journal-title":"Drug Metab. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.cbi.2006.12.009_bib52","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.clpt.2004.09.006","article-title":"Effect of tadalafil on cytochrome P450 3A4-mediated clearance: studies in vitro and in vivo","volume":"77","author":"Ring","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.cbi.2006.12.009_bib53","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0090-9556(24)15002-7","article-title":"Human hepatocytes in primary culture predict lack of cytochrome P-450 3A4 induction by eletriptan in vivo","volume":"28","author":"Pichard-Garcia","year":"2000","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.cbi.2006.12.009_bib54","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0928-0987(00)00107-X","article-title":"Induction and drug development","volume":"11","author":"Smith","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.cbi.2006.12.009_bib55","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1124\/dmd.31.4.421","article-title":"Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes","volume":"31","author":"Madan","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2006.12.009_bib56","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/00498250210128675","article-title":"Cytochrome P-450 expression in human hepatocytes and human hepatoma cell lines, Molecular mechanisms that determine the lower expression in cultured cells","volume":"32","author":"Rodr\u00edguez-Antona","year":"2002","journal-title":"Xenobiotica"},{"issue":"5","key":"10.1016\/j.cbi.2006.12.009_bib57","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1124\/dmd.30.5.608","article-title":"Induction of cytochrome P450 3A4 in primary human hepatocytes and activation of the human pregnane X receptor by tamoxifen and 4-hydroxytamoxifen","volume":"30","author":"Desai","year":"2002","journal-title":"Drug Metab. Dispos."},{"issue":"11","key":"10.1016\/j.cbi.2006.12.009_bib58","first-page":"1499","article-title":"Use of a reporter gene assay to predict and rank the potency and efficacy of CYP3A4 inducers","volume":"29","author":"El-Sankary","year":"2001","journal-title":"Drug Metab. Dispos."},{"issue":"10","key":"10.1016\/j.cbi.2006.12.009_bib59","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1124\/dmd.106.010132","article-title":"Use of immortalized human hepatocytes to predict the magnitude of clinical drug\u2013drug interactions caused by CYP3A4 induction","volume":"34","author":"Ripp","year":"2006","journal-title":"Drug Metab. Dispos."},{"issue":"7","key":"10.1016\/j.cbi.2006.12.009_bib60","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1124\/dmd.30.7.795","article-title":"CYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes","volume":"30","author":"Luo","year":"2002","journal-title":"Drug Metab. Dispos."},{"issue":"7","key":"10.1016\/j.cbi.2006.12.009_bib61","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1124\/dmd.31.7.870","article-title":"CYP3A induction by N-hydroxyformamide tumor necrosis factor-alpha converting enzyme\/matrix metalloproteinase inhibitors use of a pregname X receptor activation assay and primary hepatocyte culture for assessing induction potential in humans","volume":"31","author":"Tippin","year":"2003","journal-title":"Drug Metab. Dispos."},{"issue":"6","key":"10.1016\/j.cbi.2006.12.009_bib62","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1124\/dmd.105.007997","article-title":"Autoinduction of MKC-963 [(R)-1-(1-cyclohexylethylamino)-4-phenylphthalazine] metabolism in healthy volunteers and its retrospective evaluation using primary human hepatocytes and cDNA-expressed enzymes","volume":"34","author":"Shimizu","year":"2006","journal-title":"Drug Metab. Dispos."},{"issue":"1\/2","key":"10.1016\/j.cbi.2006.12.009_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-2797(98)00031-3","article-title":"An evaluation of the cytochrome P450 induction potential of pantoprazole in primary human hepatocytes","volume":"114","author":"Masubuchi","year":"1998","journal-title":"Chem. Biol. Interact."},{"issue":"6","key":"10.1016\/j.cbi.2006.12.009_bib64","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/004982500406426","article-title":"Expression and induction of CYP1A1\/1A2, CYP2A6 and CYP3A4 in primary cultures of human hepatocytes: a 10-year follow-up","volume":"30","author":"Meunier","year":"2000","journal-title":"Xenobiotica"},{"issue":"4","key":"10.1016\/j.cbi.2006.12.009_bib65","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1124\/dmd.31.4.439","article-title":"Comparative effects of thiazolidinediones on in vitro P450 enzyme induction and inhibition","volume":"31","author":"Sahi","year":"2003","journal-title":"Drug Metab. Dispos."},{"issue":"8","key":"10.1016\/j.cbi.2006.12.009_bib66","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0090-9556(24)15238-5","article-title":"The use of human hepatocyte cultures to study the induction of cytochrome P-450","volume":"27","author":"Kostrubsky","year":"1999","journal-title":"Drug Metab. Dispos."},{"issue":"11\/12","key":"10.1016\/j.cbi.2006.12.009_bib67","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00204-001-0287-5","article-title":"Metabolism and CYP-inducer properties of astaxanthin in man and primary human hepatocytes","volume":"75","author":"Kistler","year":"2002","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.cbi.2006.12.009_bib68","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1006\/bbrc.2000.2902","article-title":"Induction of cytochrome P450 (CYP)1A1, CYP1A2, and CYP3A4 but not of CYP2C9, CYP2C19, multidrug resistance (MDR-1) and multidrug resistance associated protein (MRP-1) by prototypical inducers in human hepatocytes","volume":"273","author":"Runge","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.cbi.2006.12.009_bib69","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S0090-9556(24)13663-X","article-title":"Effects of macrolide antibiotics on CYP3A expression in human and rat hepatocytes: interspecies differences in response to troleandomycin","volume":"28","author":"Ledirac","year":"2000","journal-title":"Drug Metab. Dispos."},{"issue":"12","key":"10.1016\/j.cbi.2006.12.009_bib70","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/j.0013-9580.2003.06203.x","article-title":"Dose-dependent induction of cytochrome P450 (CYP) 3A4 and activation of pregnane X receptor by topiramate","volume":"44","author":"Nallani","year":"2003","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.cbi.2006.12.009_bib71","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1124\/dmd.105.006569","article-title":"Human cytochrome p450 induction and inhibition potential of clevidipine and its primary metabolite h152\/81","volume":"34","author":"Zhang","year":"2006","journal-title":"Drug Metab. Dispos."},{"issue":"10","key":"10.1016\/j.cbi.2006.12.009_bib72","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/S0026-895X(24)12046-9","article-title":"CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants","volume":"28","author":"Hesse","year":"2000","journal-title":"Drug Metab. Dispos."},{"issue":"2\/3","key":"10.1016\/j.cbi.2006.12.009_bib73","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.tox.2005.12.013","article-title":"Enzyme induction in cryopreserved human hepatocyte cultures","volume":"220","author":"Kafert-Kasting","year":"2006","journal-title":"Toxicology"},{"issue":"4","key":"10.1016\/j.cbi.2006.12.009_bib74","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.clpt.2005.11.013","article-title":"MDR1 genotype is associated with hepatic cytochrome P450 3A4 basal and induction phenotype","volume":"79","author":"Lamba","year":"2006","journal-title":"Clin. Pharmacol. Ther."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279706003619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279706003619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:14:00Z","timestamp":1757855640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279706003619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0009279706003619"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2006.12.009","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induction of drug metabolizing enzymes: A survey of in vitro methodologies and interpretations used in the pharmaceutical industry\u2014Do they comply with FDA recommendations?","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2006.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}